BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35313064)

  • 1. KSR induces RAS-independent MAPK pathway activation and modulates the efficacy of KRAS inhibitors.
    Paniagua G; Jacob HKC; Brehey O; García-Alonso S; Lechuga CG; Pons T; Musteanu M; Guerra C; Drosten M; Barbacid M
    Mol Oncol; 2022 Sep; 16(17):3066-3081. PubMed ID: 35313064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEK drives BRAF activation through allosteric control of KSR proteins.
    Lavoie H; Sahmi M; Maisonneuve P; Marullo SA; Thevakumaran N; Jin T; Kurinov I; Sicheri F; Therrien M
    Nature; 2018 Feb; 554(7693):549-553. PubMed ID: 29433126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of C-RAF:KSR1 complex by DiRas3 reduces availability of C-RAF for dimerization with B-RAF.
    Baljuls A; Dobrzyński M; Rauch J; Rauch N; Kolch W
    Cell Signal; 2016 Oct; 28(10):1451-62. PubMed ID: 27368419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
    Hatzivassiliou G; Song K; Yen I; Brandhuber BJ; Anderson DJ; Alvarado R; Ludlam MJ; Stokoe D; Gloor SL; Vigers G; Morales T; Aliagas I; Liu B; Sideris S; Hoeflich KP; Jaiswal BS; Seshagiri S; Koeppen H; Belvin M; Friedman LS; Malek S
    Nature; 2010 Mar; 464(7287):431-5. PubMed ID: 20130576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice.
    Lozano J; Xing R; Cai Z; Jensen HL; Trempus C; Mark W; Cannon R; Kolesnick R
    Cancer Res; 2003 Jul; 63(14):4232-8. PubMed ID: 12874031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1.
    Müller J; Ory S; Copeland T; Piwnica-Worms H; Morrison DK
    Mol Cell; 2001 Nov; 8(5):983-93. PubMed ID: 11741534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KSR modulates signal propagation within the MAPK cascade.
    Therrien M; Michaud NR; Rubin GM; Morrison DK
    Genes Dev; 1996 Nov; 10(21):2684-95. PubMed ID: 8946910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells.
    Hoang VT; Nyswaner K; Torres-Ayuso P; Brognard J
    J Biol Chem; 2020 Jun; 295(25):8470-8479. PubMed ID: 32358059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites.
    Ory S; Zhou M; Conrads TP; Veenstra TD; Morrison DK
    Curr Biol; 2003 Aug; 13(16):1356-64. PubMed ID: 12932319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule stabilization of the KSR inactive state antagonizes oncogenic Ras signalling.
    Dhawan NS; Scopton AP; Dar AC
    Nature; 2016 Sep; 537(7618):112-116. PubMed ID: 27556948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAF inhibitor-induced KSR1/B-RAF binding and its effects on ERK cascade signaling.
    McKay MM; Ritt DA; Morrison DK
    Curr Biol; 2011 Apr; 21(7):563-8. PubMed ID: 21458265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure and functional analysis of the cysteine-rich C1 domain of kinase suppressor of Ras (KSR).
    Zhou M; Horita DA; Waugh DS; Byrd RA; Morrison DK
    J Mol Biol; 2002 Jan; 315(3):435-46. PubMed ID: 11786023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS
    Ryan MB; Coker O; Sorokin A; Fella K; Barnes H; Wong E; Kanikarla P; Gao F; Zhang Y; Zhou L; Kopetz S; Corcoran RB
    Cell Rep; 2022 Jun; 39(12):110993. PubMed ID: 35732135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAK and PI3K pathway activation confers resistance to KRAS
    Chan CH; Chiou LW; Lee TY; Liu YR; Hsieh TH; Yang CY; Jeng YM
    Br J Cancer; 2023 Jan; 128(1):148-159. PubMed ID: 36319849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras-dependent and -independent pathways target the mitogen-activated protein kinase network in macrophages.
    Büscher D; Hipskind RA; Krautwald S; Reimann T; Baccarini M
    Mol Cell Biol; 1995 Jan; 15(1):466-75. PubMed ID: 7799956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kinase activity of kinase suppressor of Ras1 (KSR1) is independent of bound MEK.
    Xing HR; Campodonico L; Kolesnick R
    J Biol Chem; 2004 Jun; 279(25):26210-4. PubMed ID: 15084597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinase suppressor of Ras inhibits the activation of extracellular ligand-regulated (ERK) mitogen-activated protein (MAP) kinase by growth factors, activated Ras, and Ras effectors.
    Joneson T; Fulton JA; Volle DJ; Chaika OV; Bar-Sagi D; Lewis RE
    J Biol Chem; 1998 Mar; 273(13):7743-8. PubMed ID: 9516483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin-stimulated cell proliferation mediated through activation of Ras/Raf/MEK/MAPK pathway in canine cultured tracheal smooth muscle cells.
    Lin CC; Shyr MH; Chien CS; Wang CC; Chiu CT; Hsiao LD; Yang CM
    Cell Signal; 2002 Mar; 14(3):265-75. PubMed ID: 11812655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism.
    Romerio F; Riva A; Zella D
    Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
    Wen-Sheng W
    Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.